Why the study?
Recent studies suggest an association between height and AF, prompting a review of the underlying structural, electrical, and genetic mechanisms linking tall stature to AF risk.
Is tall stature associated with an increased risk of atrial fibrillation development?
Is tall stature associated with an increased risk of atrial fibrillation development?
Height is an independent risk factor for atrial fibrillation, suggesting that taller individuals may benefit from earlier monitoring and preventive measures.
Answers are grounded in this paper and cite their sources.
Height may associate with AF via chamber enlargement; leaves open causal role and clinical utility.
Atrial fibrillation (AF) is characterized by abnormal heart rhythm. Among other well-known associations, recent studies suggest an association of AF with height. Height is related to 50 diseases spanning different body systems, AF is one of them. Since AF, a heterogeneous disease process, is influenced by structural, neural, electrical, and hemodynamic factors, height alters this process through its contribution to increasing atrial and ventricular size, leading to altered conduction patterns, autonomic dysregulation, and development of AF. Multiple underlying mechanisms associate height with AF. Apart from these indirect mechanisms, genome-wide association studies suggest the involvement of the same genes in AF and growth pathways. Tall stature is independently associated with a higher risk of AF development in healthy individuals. Since adult height is achieved much earlier than the onset of AF, protective measures can be taken in individuals with increased height to monitor, manage, and prevent the progression of AF.
No takes yet. Share an insight, caveat, or question.
Sohail et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: